Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > Meeting's Over ! Now play your CARDS
View:
Post by SpaceLabs on Sep 02, 2021 5:51pm

Meeting's Over ! Now play your CARDS

Great Support,lets hope Allen takes care of the Retail Investors going forward and not the Institutions only.

Big Gamble, time to RUMBLE !!!!!!!!!
Comment by ACTIONK on Sep 02, 2021 9:35pm
WHAT are you talking about now? You are the 0.3% "NO" Voter and shouldn't be a shareholder of XRX. You clearly are less then the 1% of this company and should either sell and move on or just be silent, as you don't understand this world. The last thing this company worries about is the Scumbag Retail Investor - its about the company and their bussiness plan which includes ...more  
Comment by SpaceLabs on Sep 03, 2021 4:25pm
CEO's of all Juniors are SCUMBAGS, wanting our tiny sums of money. I HOPE this CEO, Allen remembers who SUPPORTED him during DIFFICULT Times when he needed CASH to keep  XRX  AFLOAT
Comment by Moonrunner on Sep 03, 2021 10:27pm
Wait till news starts dropping next week. This is going to be over $1 by the end of the month.
Comment by SpaceLabs on Sep 05, 2021 2:42am
About time XRX gets RECOGNIZED for what is is in the PIPELINE for the World who suffer from life threatening DISEASES.
Comment by Richmond on Sep 07, 2021 3:12pm
Congrats !!!XORTEX SHAREHOLDERS!!!! $1++++ by the end of thus week!!!! $2++++ by the end of the month.... News Releases to begin!!! TIGHTEN YOUR SEATBELTS!!!!...Xortex-----GOOOOOOoooooooooo!!!!!
Comment by vitalina2233 on Sep 10, 2021 8:56am
Richmond     GROW UP   I knew i should have shorted but didn't listen to myself and bought 100k average at 70  I'm not to impressed as the penny flippers wont allow it to run  Papi
Comment by gcap1 on Sep 10, 2021 3:27pm
LMFAO Vitalina you bought this scum of a stock too woooooow your shiiit at trading !!!!....STOP BUYING Uncle BOB's pumps !!!!!...the guys a paid pumper thats how he really makes his money ! ....when buddy boy pumps that means all the insiders and friends are dumping into the strength .....lol Vatalina
Comment by Pausini on Sep 05, 2021 4:52pm
@pennyqueen summary comments for week ending Sept 3;   **Xortx** – Great week for Xortx!  The shareholders approved the rollback and funding for the Nasdaq IPO.  Bob McWhirter put the company out as his top pick and beginning Tuesday the company can start promoting itself and letting out good news.  They have been barred from promotion by the SEC as is standard with ...more  
Comment by phoenix22 on Sep 03, 2021 1:40pm
what was the final result of the share consolidation?   45 to 1    5  to 1 ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities